Cardiac amyloidosis has been underdiagnosed for decades. The echo findings are subtle enough that even experienced sonographers can miss it — and by the time it's diagnosed, the treatment window has often closed. Thankfully, ATTR-targeted therapies have changed that calculus, and identifying the right patients early enough now carries real clinical weight.
In this session, Dr. Neel Patel walks through the echocardiographic findings that should put amyloid on your differential, how to correlate them with clinical history, and what the confirmatory workup looks like once echo has flagged the diagnosis.
